Clinical Trials Sponsored by Apotex Corporation

Total 6619 results

Apotex Inc.

Unknown

A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Apotex Inc.

Completed

A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Apotex Inc.

Completed

A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Apotex Inc.

Completed

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

Actinic Keratosis
Canadian Cancer Trials Group
Apotex Inc.

Active, not recruiting

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

Ovarian Cancer Prevention

Canada, Australia
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Aronex Pharmaceuticals

Unknown

Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies

Pancreatic Neoplasms
Aronex Pharmaceuticals

Unknown

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Colorectal Neoplasms

United States
Allotex, Inc.

Recruiting

Safety and Efficacy of an Intrastromal Transform Corneal Allograft (TCA) for Presbyopia Correction - Long Term Follow-up

Presbyopia

Czechia, Ireland, Turkey, United Kingdom
BioTex, Inc.

Not yet recruiting

Pivotal Voyager Ark Device Vascular Access Study (ACT II)

Vascular Access Complication | Dialysis; Complications
Allotex, Inc.

Terminated

Safety and Efficacy of an Intrastromal Transform™ Corneal Allograft (TCA) for Presbyopia Correction

Presbyopia

Belgium, Ireland, United Kingdom
Allotex, Inc.

Withdrawn

Safety and Efficacy of a Sub-epitheilal Transform™ Corneal Allograft (TCA) for Presbyopia Correction

Refractive Errors | Presbyopia

Austria, Belgium, France, Ireland, Switzerland, United Kingdom
BioTex, Inc.

Completed

Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis

Digestive System Neoplasms | Carcinoma, Hepatocellular | Liver Neoplasms

France
BioTex, Inc.

Completed

MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors

Brain Neoplasms | Brain Cancer | Brain Tumor | Recurrent Brain Tumor

France
Aronex Pharmaceuticals

Unknown

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Neoplasms | Colorectal Neoplasms | Hepatocellular Carcinoma | Pancreatic Neoplasms | Esophageal Neoplasms | Ovarian Neoplasms

United States
Aronex Pharmaceuticals

Unknown

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Colorectal Neoplasms
Apothyx, Co.

Not yet recruiting

Topical CBD for Musculoskeletal Pain

Pain
Allotex, Inc.

Withdrawn

Safety and Efficacy of the Transform™ Corneal Allograft for Hyperopia Correction

Hyperopia

Austria, Belgium, France, Ireland, Switzerland, United Kingdom
University of Aarhus
Skanderbog Apotek

Completed

Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease (MORPHILD)

Interstitial Lung Disease | Dyspnea | Morphine

Denmark
McGill University
Weizmann Institute of Science; Apotex Inc.

Completed

Enoxacin for Amyotrophic Lateral Sclerosis (ALS) (REALS-1)

Amyotrophic Lateral Sclerosis

Canada
RedHill Biopharma Limited
National Cancer Institute (NCI); Duke University; Apogee Biotechnology Corporation

Terminated

ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma (ABC-103)

Multiple Myeloma

United States
Medical University of South Carolina
National Cancer Institute (NCI); Apogee Biotechnology Corporation

Withdrawn

A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma

Carcinoma, Hepatocellular

United States
AgoneX Biopharmaceuticals, Inc.

Not yet recruiting

A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous AGX-201 for Migraine Prophylaxis

Migraine Prophylaxis
Hanna Jangö
Region Hovedstadens Apotek

Recruiting

Oral Antibiotics After Obstetric Perineal Tear (REPAIR)

Infections | Wound Dehiscence | Obstetric Trauma

Denmark
Herlev and Gentofte Hospital
Region Hovedstadens Apotek

Recruiting

The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder

Overactive Bladder | Anesthesia, Local | Urinary Tract Infections | Pain, Procedural | Urge Incontinence | Hematuria

Denmark
Region Hovedstadens Apotek
Copenhagen University Hospital, Hvidovre

Completed

Interdisciplinary Medication Review Interventions in an Integrated Outpatient Department. (FMA-CPH)

Cognitive Impairment | Multimorbidity | Comorbidity | Language Problems | Drug Prescribing

Denmark
Michael Savona
Incyte Corporation; Astex Pharmaceuticals, Inc.; Theradex

Recruiting

Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO) (ABNL-MARRO)

MDS/MPN

United States
Acotec Scientific Co., Ltd

Recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries.

Peripheral Arterial Disease (PAD) | Peripheral Vascular Disease (PVD)

China
Acotec Scientific Co., Ltd

Recruiting

ACOART BTK RENEW：A Post Market Clinical Study

Peripheral Artery Disease

China
Acotec Scientific Co., Ltd

Completed

Effectiveness and Safety Study of Peripheral Balloon Dilatation Catheter in Percutaneous Transluminal Angioplasty(PTA) Procedure

Peripheral Arterial Disease

China
Acotec Scientific Co., Ltd

Recruiting

Acotec DCB Post Market Clinical Follow-up (FLOWER)

Peripheral Artery Disease

Germany
Acotec Scientific Co., Ltd

Completed

AcoArt III / Arterio-venous Fistula in China

Arteriovenous Fistula Stenosis

China
Acotec Scientific Co., Ltd

Completed

AcoArt Ⅱ/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China

Peripheral Artery Disease

China
Acotec Scientific Co., Ltd

Completed

AcoArt Ⅰ / SFA China

Peripheral Artery Disease

China
Astex Pharmaceuticals, Inc.

Recruiting

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment

Acute Myeloid Leukemia | Myelodysplastic Syndromes

Spain, Poland, Bulgaria, Lithuania, Slovakia, Romania
Astex Pharmaceuticals, Inc.

Recruiting

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment

Acute Myeloid Leukemia | Myelodysplastic Syndromes

Spain, Poland, Bulgaria, Lithuania, Slovakia, Romania
Astex Pharmaceuticals, Inc.

Active, not recruiting

A Study of TAS1440 With ATRA in Subjects With r/r AML

Acute Myeloid Leukemia

United States
Astex Pharmaceuticals, Inc.

Active, not recruiting

Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53

Solid Tumor

United States
Astex Pharmaceuticals, Inc.

Completed

Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs

Myelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic

United States, Spain, Korea, Republic of, France, Denmark, Canada, Germany, Italy, Czechia, United Kingdom, Poland, Japan, Sweden, Belgium
Astex Pharmaceuticals, Inc.

Terminated

Guadecitabine Extension Study

Acute Myeloid Leukemia | Myeloid Dysplastic Syndrome

United States, Taiwan, Korea, Republic of, Canada, Spain, Japan, Italy, Austria, Denmark
Astex Pharmaceuticals, Inc.

Terminated

A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States
Astex Pharmaceuticals, Inc.

Completed

Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies

Solid Tumors

United States
Astex Pharmaceuticals, Inc.

Completed

A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate

Prostate Cancer

United States, United Kingdom, Spain, Canada
Apnex Medical, Inc.

Completed

Australian Clinical Study of the Apnex Medical HGNS System to Treat Obstructive Sleep Apnea

Obstructive Sleep Apnea
Astex Pharmaceuticals, Inc.

Terminated

Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer

Pancreatic Cancer

United States
Astex Pharmaceuticals, Inc.

Completed

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Chronic Myelogenous Leukemia

United States, Canada
Ulla Toft
Region Hovedstadens Apotek

Active, not recruiting

Pilot Project for Direct Access to Physical Therapy

Musculoskeletal Diseases

Denmark
Ringkobing Love Apotek
Ministry of Health and Prevention

Completed

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

Polypharmacy

Denmark
Acotec Scientific Co., Ltd

Recruiting

ACOART AVF RENEW: A Post Market Clinical Study

Stenosis of Native Hemodialysis Arteriovenous Fistulas

China
Acotec Scientific Co., Ltd

Recruiting

Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis

Peripheral Artery Disease

China

Clinical Trials Sponsored by Apotex Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations